Table 1 Baseline Clinical and Demographic Features

Number

1073

Females

N (%)

698 (65 %)

Age

Years

58 (±14)

BMI

BMI >30 N (%)

28 (±6.3)

358 (33 %)

Alcohol Excess^a Males

N (%) Females

31 (8 %)

37 (5 %)

Current Smoker

N (%)

286 (27 %)

Rheumatoid Factor Positive

N (%)

772 (72 %)

Anti-CCP Antibody Positive

N (%)

659 (61 %)

Symptom duration until diagnosis^b, days

163

(IQR 97–323)

DAS28

4.74 (±1.34)

28 Swollen Joint Count

7 (±6)

28 Tender Joint Count

8 (±7)

Patient Global 100mmVAS

52 (±28)

Physician Global 100 mm VAS

45 (±24)

Pain 100 mm VAS

52 (±28)

HAQ

1.17 (±0.8)

EQ5D Index

0.51 (±0.32)

HAD Anxiety Scale ≥11

N (%)

208 (19 %)

HAD Depression Scale ≥11

N (%)

138 (13 %)

ESR^b

22 (IQR 12–41)

CRP^b

12 (IQR 5–33)

Commenced Methotrexate

N (%)

810 (75 %)

Modified Sharp Score – Hands and Feet

Erosion score^b

Joint space narrowing score^b

Total Sharp Score^b

0 (IQR 0–3.0)

0 (IQR 0–4.0)

2 (IQR 0–7.0)